Elitra Pharmaceuticals Inc.

NovaBay Pharmaceuticals, a US clinical-stage company developing non-antibiotic anti-infective compounds for the treatment or prevention of a range of bacterial, viral and fungal infections, has appoin

Tracking the progress of a group of biotechs founded in the late ’90s yields some important lessons for today’s entrepreneurs. Nancy Dvorin and Melanie Senior Laying out a strategy is one thing; execu

Novel antibiotics through amoeba-based screening When Pharmacia Corp.'s (now Pfizer Inc. [See Deal] ) linezolid ( Zyvox ) was launched in 2000, it was the first antibiotic with a novel mechanism o

Cutting the lines of bacterial communication Biofilms, highly structured and virulent communities of surface colonizing bacteria, are patient, yet lethal invaders. Through a cell-cell signaling proces